Friday, October 17, 2008

I'm announcing a name change

for the next 3 weeks I want to be known as 'Joe the Plumber'

Wednesday, October 15, 2008

Injured student’s suit against Tecumseh schools dismissed

That's the headline from a Michigan newspaper website. The story's lead:

A lawsuit against the Tecumseh school district and an elementary teacher over bullying injuries a first-grade student with hemophilia suffered in 2005 was tossed out of Lenawee County Circuit Court on Monday.


Man! First of all bullying injuries in first grade! Hemophilia or not what the ...?
From the report:

Michael suffered severe injuries when his arm was twisted behind his back...

Now we can't know all the details from just a news article but what's going on. I'm not sure these incidents called for a lawsuit but certainly they raise some questions about the supervision or discipline at the school, child with hemophilia or not.

As parents of a child with hemophilia we strive to emphasize that Jack is not to be treated differently or excluded from school activities. He doesn't need special attention save in the event
that an injury does happen and then he needs specific medical treatment.

So with that in mind these comments (for the purpose of a lawsuit!) stung:

“They knew he had severe hemophilia. They knew they had to protect him,” argued Hanson’s attorney, James Cmejrek. Although the teacher was not in the lunch room where the second injury occurred, Cmejrek said she failed to instruct lunch room monitors to give Michael special protection because of his condition... (italics mine)



Kogenate FS approved for Daily prophylaxis

The FDA has approved a "new use" for Kogenate FS.

FDA quote:
"Administering Kogenate FS to children with hemophilia A on a daily basis before a bleeding event occurs will reduce bleeding into joints and help prevent joint damage, a major cause of disability in hemophiliacs," said Dr. Jesse Goodman, director of the agency's Center for Biologics Evaluation and Research. (italics mine)

Nice bit of marketing juice for Bayer's Kogenate FS. But perhaps an underlying benefit is to signal an acknowledgement for insurers that a robust prophylactic regime should be fully embraced and properly covered.